DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

MDW aims to combat radiologist shortage with blockchain Connecting radiologists seeking volume to the facilities that need reading support

United Imaging Healthcare makes US debut at RSNA Bringing MR, CT, X-ray and PET/CT manufacturing to Houston

Dr. Hermann Requardt United Imaging Healthcare appoints senior scientific advisor

Dr. Jaewon Ryu Geisinger appoints interim president and CEO

Dr. Kent Thielen Mayo Clinic appoints CEO of its Florida operations; board of trustees names two new members

Medical charities do measurable good in the world A look at some organizations bringing goods and services where they are needed most

Mike Lobinsky EOS Imaging appoints new President North America

Merit Medical Systems closes acquisition of Cianna Medical Deal worth $135 million with possible additional incentivized payments

Clinical wearables – remaining competitive in an evolving market Insights from Ravi Kuppuraj, Business Leader of Connected Sensing Venture for Philips

Driving premium platform valuations for future growth The radiology M&A market is red hot, help investors see the value in your business

Philips Trilogy 100

Philips study shows noninvasive home ventilation can reduce COPD readmissions

by John W. Mitchell , Senior Correspondent
Patients suffering a common, often deadly, respiratory condition who went home from the hospital supported by more technologically advanced noninvasive ventilation (NIV) were less likely to be readmitted to the hospital — resulting in cost savings of nearly half a million dollars over 90 days — according to a study published in the journal Value in Health.

The study, sponsored by Philips, calculated the cost savings based on the home use of its advanced Trilogy 100 portable ventilator with AVAPS-AE mode on 250 patients with severe chronic obstructive pulmonary disease (COPD) following their discharge from the hospital. This was compared to patients who did not receive advanced care NIV treatments or did not receive NIV treatment at all.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



"Noninvasive ventilation (NIV) assists patients with their breathing by providing a prescribed pressure or volume of air during inhalation," Dr. Teofilo Lee-Chiong, Chief Medical Liaison for Philips and professor of medicine at National Jewish Hospital and the University of Colorado, told HCB News. "Newer technologies, such as the AVAPS-AE mode used in the study with Philips Trilogy, are more responsive to the patient's ever-changing breathing needs."

The study determined a $402,981 savings over 30 days and $449,101 savings over 90 days for 250 patients. Further, in a related payor base case analysis of 100,000 patients, the study calculated a three-year savings of $326 million for patients treated with the advanced care NIV and $1.04 billion in savings compared to no NIV treatment.

According to Lee-Chiong, AVAPS-AE, or automated mode, continuously adjusts respiratory pressure to clinical targets best for the individual patient. This, he said, increases patient comfort, as it matches up with an individual's breathing pattern.

COPD is one of the most common, yet most under-diagnosed diseases in the world, according to Philips. It affects 384 million people worldwide and is the third leading cause of death in the U.S.

Morbidity aside, COPD is one of the leading contributors to rising health care costs due to inpatient hospital admissions. It's estimated that the health economic burden of COPD will reach $50 billion by 2020.

"We wanted to assess whether a comprehensive strategy of care, including the use of newer, more advanced noninvasive ventilators, can reduce the economic burden of managing patients with moderate-to-severe COPD," said Lee-Chiong.

He said that NIV is a proven protocol to improve survival rates, enhance quality of life and reduce hospital readmissions. Philips believed developing an NIV-automated delivery approach individualized to each patient would offer further improvements for patients and help control health care spending.

"I believe that science and imagination will continue to create novel technologies that improve quality of life, prolong survival, and allow patients with COPD to live their fullest lives," said Lee-Chiong.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED